Clinical Trial

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveillance.
Protocol Amendment History 19 amendments
This ClinicalTrials.gov record has been amended 19 times since 2018-12-06; most recent amendment 2026-06-11.
Status change: Not Yet Recruiting → Recruiting 2019-03-21
Trial Details
NCT Number NCT03769766
Lead Sponsor University of Texas Southwestern Medical Center
Conditions Prostate Cancer
Enrollment 291 participants
Start Date 2019-03-11
Primary Completion 2029-11 (estimated)
Study Completion 2030-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-15